We are a biotechnology company dedicated to developing novel, chemically-derived allogeneic cell therapies for treating degenerative diseases such as Parkinson's Disease, Retinal Degenerative Diseases, and Ischemic Stroke. Our lead pipeline candidate, NouvNeu001, is set to initiate Phase I clinical ...See more
Headquarters:
China
Company Type:
SME
Company size:
51-200 Employees
Year Founded:
2017 (9 years)
Address:
9 GAOKEYUAN 3RD RD, EAST LAKE HIGH-TECH DEVELOPMENT ZONE; WUHAN, HUBEI, CN
HIGH
spending power